Im a relatively new holder of Imu shares and hopelly a long term...

Im a relatively new holder of Imu shares and hopelly a long term candidate. From my research I believe it's research and dedication to immunology is disruptive and although I barely understand the science i thought it's Ip to be unique. By happenstance I read today An article in the current Time magazine devoted to the 100 most influential persons in the world, including one Carl Jude. The article written by a 12 year old cancer survivor tells of undergoing experimental T cell therapy treatment pioneered by Carl Jude when she was 7 years old and after going into a coma surviving to become cancer free. My curiosity was piqued and although I have not researched Jude and his science I ask of those fellow posters whether there is any similarity between what our scientists are doing and whether it's competitive with Jude and his science. Have a feeling I'm putting this across badly but I suppose I'm also thinking negatively if he succeeded so admirably with a human and has been busy with this technique for a long time and we are still at the formative stage with rats, mice and sparse human trials. Any input would be appreciated. Thanks. Karrotz